A Natural Guided Missile of Beneficial Bacteria Found in Infant Oral Cavities

Antibiotic resistance is widely considered one of the greatest threats to modern medicine. As humankind searches for new alternatives due to the emergence of "superbugs" that resist conventional antibiotics, a next-generation natural antibacterial substance is receiving intense attention from both academia and industry. This is ‘Paragassericin,’ a novel substance discovered in South Korea for the first time in the world.

The Evolution of 'Bacteriocins,' the Next-Generation Antibacterial Agents

To understand the innovativeness of Paragassericin, one must first understand 'Bacteriocins.' Bacteriocins are natural antibacterial peptides produced by microorganisms to gain a competitive edge in their survival environments.

Acting like a "natural guided missile," they eliminate specific harmful bacteria by puncturing pores in their cell membranes. Because they are easily broken down by human digestive enzymes, they leave no residual issues in the body and exhibit virtually no toxicity to host cells, making them remarkably safe.

Currently, the most widely commercialized bacteriocin is 'Nisin,' which is recognized for its safety by the US FDA and used globally as a natural preservative in cheeses and canned foods, alongside 'Pediocin,' which suppresses Listeria. However, the newly discovered Paragassericin boasts unprecedented capabilities that shatter conventional standards.

A Miracle from Infant Oral Cavities: The ‘Selective Killing’ Mechanism

Paragassericin was originally isolated and discovered in the oral cavities of infants. The most powerful weapon that sets this new substance apart from traditional antibiotics is its ‘Precision Targeting’ capability.

While conventional antibiotics indiscriminately destroy both beneficial and harmful bacteria, devastating the body's microbiome ecosystem, Paragassericin leaves beneficial bacteria completely intact while selectively identifying and eliminating specific harmful pathogens, such as cavity-causing bacteria. In short, it possesses the groundbreaking ability to eliminate only the target pathogens responsible for disease while minimizing side effects.

Strong Biofilm Inhibition and Industrial Scalability

The commercial value of Paragassericin is boundless. The most immediate impact is expected in the oral healthcare sector, as it has been proven to powerfully inhibit the formation of biofilms (bacterial plaques) that cause cavities and periodontal diseases.

Furthermore, it holds immense value as a safe, natural food preservative capable of replacing chemical alternatives. Ultimately, it is emerging as a highly promising therapeutic candidate to resolve the global challenge of antibiotic resistance.

K-Bio Secures Monopoly Status in the Global Market

The discovery of Paragassericin goes beyond a mere academic achievement. Developed through domestic technological prowess for the first time globally, it has successfully secured composition patents, establishing an airtight monopoly in the global microbiome and natural antibacterial substance markets.

Facing the global crisis of antibiotic resistance, nature has provided a new answer: Paragassericin. Attention is now focused on how this small yet astonishing natural substance will drive innovation across the global bio and medical industries far beyond oral healthcare.